SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005590
Filing Date
2017-08-01
Accepted
2017-08-01 16:01:44
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20170630x10q.htm 10-Q 1558912
2 EX-10.5 rigl-20170630ex105a36db9.htm EX-10.5 215028
3 EX-10.6 rigl-20170630ex10689f72f.htm EX-10.6 154199
4 EX-31.1 rigl-20170630ex311a4edad.htm EX-31.1 17756
5 EX-31.2 rigl-20170630ex312fc0c90.htm EX-31.2 17778
6 EX-32.1 rigl-20170630ex3212a73be.htm EX-32.1 9416
  Complete submission text file 0001558370-17-005590.txt   5068141

Data Files

Seq Description Document Type Size
7 EX-101.INS rigl-20170630.xml EX-101.INS 898170
8 EX-101.SCH rigl-20170630.xsd EX-101.SCH 33559
9 EX-101.CAL rigl-20170630_cal.xml EX-101.CAL 35893
10 EX-101.DEF rigl-20170630_def.xml EX-101.DEF 106733
11 EX-101.LAB rigl-20170630_lab.xml EX-101.LAB 292904
12 EX-101.PRE rigl-20170630_pre.xml EX-101.PRE 206832
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 17996722
SIC: 2834 Pharmaceutical Preparations